Search results for " turoctocog alfa"

showing 1 items of 1 documents

Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C

2021

Mariasanta Napolitano,1 Arne Agerlin Olsen,2 Anne Mette Nøhr,2 Hermann Eichler3 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo Reference Regional Center for Thrombosis and Hemostasis, Hematology Unit, Palermo, Italy; 2Novo Nordisk A/S, Biopharm Manufacturing Development, Gentofte, Denmark; 3Saarland University and Saarland University Hospital, Institute of Clinical Haemostaseology and Transfusion Medicine, Homburg (Saar), GermanyCorrespondence: Anne Mette NøhrBiopharm Manufacturing Development, Novo Nordisk A/S, Nybrovej 80, Gentofte 2820, DenmarkTel +45 3075 1619Email amnq@novonordisk.…

medicine.medical_specialtybusiness.industryturoctocog alfa pegolHematologyTuroctocog alfa030204 cardiovascular system & hematologyGastroenterologyJournal of Blood Medicine03 medical and health sciences0302 clinical medicinetemperature stabilityfactor VIII030220 oncology & carcinogenesisAmbient humidityInternal medicinehemic and lymphatic diseasesmedicinePotencyfactor VIII hemophilia A storage flexibility temperature stability turoctocog alfa turoctocog alfa pegolhemophilia Astorage flexibilityturoctocog alfabusinessHot and humidOriginal ResearchJournal of Blood Medicine
researchProduct